Damianaki A - Search Results

1

Impaired proliferative potential of bone marrow mesenchymal stromal cells in patients with myelodysplastic syndromes is associated with abnormal WNT signaling pathway.

Pavlaki K, Pontikoglou CG, Demetriadou A, Batsali AK, Damianaki A, Simantirakis E, Kontakis M, Galanopoulos A, Kotsianidis I, Kastrinaki MC, Papadaki HA. Pavlaki K, et al. Among authors: damianaki a. Stem Cells Dev. 2014 Jul 15;23(14):1568-81. doi: 10.1089/scd.2013.0283. Epub 2014 Apr 21. Stem Cells Dev. 2014. PMID: 24617415

2

Mesenchymal stem cells contribute to the abnormal bone marrow microenvironment in patients with chronic idiopathic neutropenia by overproduction of transforming growth factor-β1.

Stavroulaki E, Kastrinaki MC, Pontikoglou C, Eliopoulos D, Damianaki A, Mavroudi I, Pyrovolaki K, Katonis P, Papadaki HA. Stavroulaki E, et al. Among authors: damianaki a. Stem Cells Dev. 2011 Aug;20(8):1309-18. doi: 10.1089/scd.2010.0425. Epub 2010 Dec 27. Stem Cells Dev. 2011. PMID: 21047210

3

Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.

Batsali AK, Pontikoglou C, Koutroulakis D, Pavlaki KI, Damianaki A, Mavroudi I, Alpantaki K, Kouvidi E, Kontakis G, Papadaki HA. Batsali AK, et al. Among authors: damianaki a. Stem Cell Res Ther. 2017 Apr 26;8(1):102. doi: 10.1186/s13287-017-0555-9. Stem Cell Res Ther. 2017. PMID: 28446235 Free PMC article.

4

Impaired granulocytopoiesis in patients with chronic idiopathic neutropenia is associated with increased apoptosis of bone marrow myeloid progenitor cells.

Papadaki HA, Eliopoulos AG, Kosteas T, Gemetzi C, Damianaki A, Koutala H, Bux J, Eliopoulos GD. Papadaki HA, et al. Among authors: damianaki a. Blood. 2003 Apr 1;101(7):2591-600. doi: 10.1182/blood-2002-09-2898. Epub 2002 Nov 27. Blood. 2003. PMID: 12517813 Free article.

5

Increased levels of soluble flt-3 ligand in serum and long-term bone marrow culture supernatants in patients with chronic idiopathic neutropenia.

Papadaki HA, Damianaki A, Pontikoglou C, Pyrovolaki K, Eliopoulos DG, Stavroulaki E, Eliopoulos GD. Papadaki HA, et al. Among authors: damianaki a. Br J Haematol. 2006 Mar;132(5):637-9. doi: 10.1111/j.1365-2141.2005.05903.x. Br J Haematol. 2006. PMID: 16445839 Free article.

6

Impaired megakaryopoiesis in patients with chronic idiopathic neutropenia is associated with increased transforming growth factor beta1 production in the bone marrow.

Psyllaki M, Damianaki A, Gemetzi C, Pyrovolaki K, Eliopoulos GD, Papadaki HA. Psyllaki M, et al. Among authors: damianaki a. Br J Haematol. 2006 Sep;134(6):624-31. doi: 10.1111/j.1365-2141.2006.06242.x. Br J Haematol. 2006. PMID: 16938119 Free article.

7

Pro-inflammatory bone marrow milieu in patients with chronic idiopathic neutropenia is associated with impaired local production of interleukin-10.

Koumaki V, Damianaki A, Ximeri M, Pontikoglou C, Axioti F, Spanoudakis M, Eliopoulos GD, Papadaki HA. Koumaki V, et al. Among authors: damianaki a. Br J Haematol. 2006 Nov;135(4):570-3. doi: 10.1111/j.1365-2141.2006.06345.x. Epub 2006 Oct 10. Br J Haematol. 2006. PMID: 17054669 Free article.

8

Investigation of bone marrow mesenchymal stem cells (BM MSCs) involvement in Idiopathic Pulmonary Fibrosis (IPF).

Antoniou KM, Papadaki HA, Soufla G, Kastrinaki MC, Damianaki A, Koutala H, Spandidos DA, Siafakas NM. Antoniou KM, et al. Among authors: damianaki a. Respir Med. 2010 Oct;104(10):1535-42. doi: 10.1016/j.rmed.2010.04.015. Epub 2010 May 18. Respir Med. 2010. PMID: 20483575 Free article.

9

Minor populations of paroxysmal nocturnal hemoglobinuria-type cells in patients with chronic idiopathic neutropenia.

Damianaki A, Stagakis E, Mavroudi I, Spanoudakis M, Koutala H, Papadogiannis F, Kanellou P, Pontikoglou C, Papadaki HA. Damianaki A, et al. Eur J Haematol. 2016 Dec;97(6):538-546. doi: 10.1111/ejh.12766. Epub 2016 May 25. Eur J Haematol. 2016. PMID: 27124520

10

Increased proportion and altered properties of intermediate monocytes in the peripheral blood of patients with lower risk Myelodysplastic Syndrome.

Velegraki M, Papakonstantinou N, Kalaitzaki L, Ntoufa S, Laidou S, Tsagiopoulou M, Bizymi N, Damianaki A, Mavroudi I, Pontikoglou C, Papadaki HA. Velegraki M, et al. Among authors: damianaki a. Blood Cells Mol Dis. 2021 Feb;86:102507. doi: 10.1016/j.bcmd.2020.102507. Epub 2020 Sep 28. Blood Cells Mol Dis. 2021. PMID: 33032166

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page